Company Creates Bioethics Panel on Trial Drugs

Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients’ requests for lifesaving medicines before they are approved.









from NYT > Health http://ift.tt/1Iis2gt
via health&fitness